{
    "nctId": "NCT02771353",
    "briefTitle": "The HeartSpare Plus 1B Trial",
    "officialTitle": "The HeartSpare Plus 1B Trial: A Randomised Phase II Trial Comparing the Resource Impact, Acute Toxicity and Feasibility of Different Pan-lymph Node Radiotherapy Techniques for Breast Cancer Patients",
    "overallStatus": "COMPLETED",
    "conditions": "Breast Cancer",
    "studyType": "INTERVENTIONAL",
    "phase": "PHASE2",
    "allocation": "RANDOMIZED",
    "primaryPurpose": "TREATMENT",
    "enrollmentCount": 39,
    "primaryOutcomeMeasure": "Linear Accelerator time",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* Age \u226518 years\n* Female or male\n* Invasive carcinoma of the breast (left or right-sided)\n* Breast conservation surgery or mastectomy\n* Axillary staging and/or dissection\n* pT1-T4,N1-2,M0 disease\n* Histological involvement of axillary lymph nodes\n* Indication for radiotherapy to the IMC, axillary levels I-III and/or level IV\n* Patient able to tolerate breath hold\n* Performance status 0-1\n\nExclusion Criteria:\n\n* Contralateral and/or previous ipsilateral breast cancer, irrespective of date of diagnosis\n* Past medical history of malignancy except (i) basal cell skin carcinoma, (ii) CIN cervix uteri, (iii) non-breast malignancy allowed if treated with curative intent and at least 5 years disease free\n* Previous radiotherapy to any region above the diaphragm",
    "sex": "FEMALE",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}